KPTI
|Karyopharm Therapeutics Inc
NASDAQ
USD 4.26
-0.08|-1.84%
Current Price
USD 4.26
Change
USD -0.08 (-1.84%)
P/E Ratio
Dividend Yield
Market Cap
39.14M
Volume
54,509
Open
USD 4.17
Previous Close
USD 4.34
52-Week High
USD 17.40
52-Week Low
USD 3.51
About Karyopharm Therapeutics Inc
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases in the United States. The company discovers, develops, and commercializes novel and small molecule Selective Inhibitor of Nuclear Export (SINE) compounds that inhibit the nuclear export protein exportin 1 (XPO1). Its lead compound, include XPOVIO in combination with bortezomib and dexamethasone for th...
Sector:Healthcare
Industry:Biotechnology
CEO:Mr. Richard A. Paulson M.B.A.
Employees:279
Headquarters:Newton, USA
Website:www.karyopharm.com
Dividend History
Dividend Payments
| Declared Date | Record Date | Payment Date | Amount | Frequency |
|---|
Similar Companies
Explore Stocks by Sector
technology
finance
healthcare
Frequently Asked Questions